Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning

被引:223
作者
Fändrich, F
Lin, XB
Chai, GX
Schulze, M
Ganten, D
Bader, M
Holle, J
Huang, DS
Parwaresch, R
Zavazava, N
Binas, B
机构
[1] Univ Kiel, Dept Gen Surg & Thorac Surg, D-24105 Kiel, Germany
[2] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA
[4] Univ Kiel, Inst Hematopathol, D-24105 Kiel, Germany
[5] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[6] VA Med Ctr, Iowa City, IA USA
[7] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA
关键词
D O I
10.1038/nm0202-171
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hematopoietic stem cells have been successfully employed for tolerance induction in a variety of rodent and large animal studies. However, clinical transplantation of fully allogeneic bone marrow or blood-borne stem cells is still associated with major obstacles, such as graft-versus-host disease or cytoreductive conditioning-related toxicity. Here we show that when rat embryonic stem cell-like cells of WKY origin are injected intraportally into fully MHC-mismatched DA rats, they engraft permanently (>150 days) without supplementary host conditioning. This deviation of a potentially alloreactive immune response sets the basis for long-term graft acceptance of second-set transplanted WKY cardiac allografts. Graft survival was strictly correlated with a state of mixed chimerism, which required functional thymic host competence. Our results provide a rationale for using preimplantation-stage stem cells as vehicles in gene therapy and for the induction of long-term graft acceptance.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 39 条
[1]   Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts [J].
Allison, J ;
Georgiou, HM ;
Strasser, A ;
Vaux, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) :3943-3947
[2]  
Bianchi DW, 1998, J PERINAT MED, V26, P175
[3]   IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES) [J].
CORDELL, JL ;
FALINI, B ;
ERBER, WN ;
GHOSH, AK ;
ABDULAZIZ, Z ;
MACDONALD, S ;
PULFORD, KAF ;
STEIN, H ;
MASON, DY .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) :219-229
[4]   Different in vivo tolerogenicity of MHC class I peptides [J].
Fändrich, F ;
Zhu, XF ;
Schröder, J ;
Dresske, B ;
Henne-Bruns, D ;
Oswald, H ;
Zavazava, N .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (01) :16-27
[5]  
FERRARA JL, 1989, BIOL BLOOD MARROW TR, V5, P347
[6]   H-2 ANTIGENS OF THYMUS DETERMINE LYMPHOCYTE SPECIFICITY [J].
FINK, PJ ;
BEVAN, MJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (03) :766-775
[7]   Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover [J].
French, LE ;
Hahne, M ;
Viard, I ;
Radlgruber, G ;
Zanone, R ;
Becker, K ;
Muller, C ;
Tschopp, J .
JOURNAL OF CELL BIOLOGY, 1996, 133 (02) :335-343
[8]  
George JF, 1999, INT J MOL MED, V4, P475
[9]   An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow [J].
George, JF ;
Sweeney, SD ;
Kirklin, JK ;
Simpson, EM ;
Goldstein, DR ;
Thomas, JM .
NATURE MEDICINE, 1998, 4 (03) :333-335
[10]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192